Multicenter study on the treatment of cerebralcare granule for patients with mild and moderate vascular cognitive impairment
10.3760/cma.j.issn.1674-6554.2018.05.005
- VernacularTitle:养血清脑颗粒治疗轻中度血管性认知障碍患者多中心研究
- Author:
Peiyuan LYU
1
;
Liwen TAI
;
Ruisheng DUAN
;
Yanhong DONG
;
Qingrui LIU
;
Jianguo ZHU
;
Wenfeng HUA
;
Yongqiu LI
;
Yanmin GUO
;
Dabao SUN
;
Yuqing WEI
;
Xudong XIE
;
Jianhua WANG
;
Suju SUN
;
Xin GUO
Author Information
1. 河北省人民医院神经内科
- Keywords:
Cerebralcare granule;
Vascular cognitive impairment;
MMSE;
MoCA
- From:
Chinese Journal of Behavioral Medicine and Brain Science
2018;27(5):405-410
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the improvement of cognitive impairment in patients with mild and moderate vascular cognitive impairment( VCI) treated with cerebralcare granule ( CG) and basic treat-ment.Methods From October in 2014 to December in 2016 year,143 cases of VCI patients were admitted from six hospitals in some areas of Hebei Province as the research objects,and divided into CG treatment group (experimental group,n=98) and conventional treatment group (control group,n=66).Three months and six months after treatment,the score of mental state examination ( MMSE) ,the Montreal cognitive assess-ment scale ( MoCA) and the daily living capacity scale( ADL) of the two groups were compared after 3 and 6 moths of treatment.Results ①The total score of MMSE in the experimental group was higher than that of the control group for six months after treatment, and the difference was statistically significant ( ( 23. 76 ± 4.02) vs (21.52±5.13),P<0.05).②Six months after treatment,the total score of MoCA ((21.06±4.66) vs (18.32±5.20)) and visual spatial/executive function((3.05±1.37) vs (2.42±1.66)),calculation force ((2.24±0.84) vs (1.83±1.05)) and orientation ability((5.20±1.12) vs (4.06±1.35)) scores in the ex-perimental group were significantly higher than those in the control group (P<0.05) .③Six months after treat-ment,the ADL score in the experimental group was lower than that before treatment,and the difference was statistically significant((24.96±8.74) vs (29.20±11.55),P<0.05);while there was no significant difference in the ADL score between the experimental group and the control group after 6 months (P>0.05).Conclusion CG can improve cognitive function in mild to moderate VCI patients,mainly in visual space/execution func-tion,calculation ability and orientation ability,and with the extension of treatment time,the curative effect is more obvious.